00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|126/13|
00000000|MMI|3.63|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|100/14|
00000000|MMI|3.63|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|100/14|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.50|Congestive heart failure|C0018802|[dsyn]|["CONGESTIVE HEART FAILURE"-tx-1-"congestive heart failure"-noun-0]|TX|65/24|
00000000|MMI|3.46|+2|C0740116|[qnco]|["+2"-tx-1-"2"-fraction-0]|TX|116/1|
00000000|MMI|3.46|2+|C3833492|[fndg]|["2+"-tx-1-"2"-fraction-0]|TX|116/1|
00000000|MMI|3.46|2+ Score|C2827735|[qnco]|["2+"-tx-1-"2"-fraction-0]|TX|116/1|
00000000|MMI|3.46|2+ Score, WHO|C2981700|[clas]|["2+"-tx-1-"2"-fraction-0]|TX|116/1|
00000000|MMI|3.46|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|94/3|
00000000|MMI|3.46|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|94/3|
00000000|MMI|125.87|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-21-"DISCHARGE"-noun-0,"Discharge"-tx-20-"DISCHARGE"-verb-0,"Discharge"-tx-4-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|3456/9;3313/9;1471/9;332/9;33/9;119/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|75.96|Portugal|C0032729|[geoa]|["PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|1187/2;1023/2;[395/2],[434/2],[686/2],[820/2],[888/2]|Z01.542.727
00000000|MMI|68.28|Coding|C0009219|[ocac]|["code"-tx-20-"CODE"-noun-0,"code"-tx-2-"CODE"-noun-0,"code"-tx-2-"code"-noun-0]|TX|3234/4;279/4;297/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|67.86|Mongolia|C0026410|[geoa]|["MG"-tx-4-"MG"-noun-0,"MG"-tx-3-"MG"-noun-0,"MG"-tx-2-"MG"-noun-0]|TX|1184/2;1020/2;[392/2],[431/2],[885/2]|Z01.252.474.651
00000000|MMI|59.03|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-11-"lasix"-noun-0,"Lasix"-tx-8-"lasix"-noun-0,"Lasix"-tx-2-"LASIX"-noun-0]|TX|2635/5;2283/5;498/5|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|58.21|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-13-"ASA"-noun-0,"ASPIRIN"-tx-2-"ASPIRIN"-noun-0]|TX|2774/3;363/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|54.84|Zocor|C0678181|[orch,phsu]|["Zocor"-tx-13-"zocor"-noun-0,"Zocor"-tx-2-"ZOCOR"-noun-0]|TX|2780/5;860/5|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|54.27|Nephrectomy|C0027695|[topp]|["NEPHRECTOMY"-tx-16-"nephrectomy"-noun-0,"NEPHRECTOMY"-tx-4-"nephrectomy"-noun-0]|TX|2945/11;[1687/11],[1705/11],[2002/11]|E04.950.774.435
00000000|MMI|49.46|Inferior Wall Myocardial Infarction|C0340305|[dsyn]|["imi"-tx-6-"IMI"-noun-0,"imi"-tx-4-"IMI"-noun-0]|TX|2148/3;[1784/3],[2037/3]|C14.280.647.500.187;C14.907.585.500.187
00000000|MMI|49.06|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-3-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-2-"Food/Drug Interaction"-noun-0]|TX|1029/21;[441/21],[895/21]|G07.690.773.968.511
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-4-"DIAGNOSIS"-noun-0]|TX|[1446/9],[1571/9]|x.x.x.x.x.x.x
00000000|MMI|42.15|Toprol-XL|C0723783|[orch,phsu]|["Toprol XL"-tx-12-"Toprol XL"-noun-0,"Toprol XL"-tx-3-"TOPROL XL"-noun-0]|TX|2693/9;977/9|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|39.84|Diet|C0012155|[food]|["Diet"-tx-4-"DIET"-noun-0]|TX|[1193/4],[1227/4],[1294/4]|G07.203.650.240
00000000|MMI|35.02|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-4-"HTN"-noun-0,"HTN"-tx-4-"htn"-noun-0,"HYPERTENSION"-tx-4-"hypertension"-noun-0]|TX|1992/3;1719/3;1725/12|C14.907.489
00000000|MMI|32.37|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-2-"LISINOPRIL"-noun-0]|TX|[554/10],[741/10]|D12.644.456.345.600
00000000|MMI|32.36|Fluorides|C0016327|[inch,phsu]|["F-"-tx-15-"f"-noun-0,"F-"-tx-9-"F"-noun-0]|TX|2857/1;2462/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|32.33|Dominican Republic|C0013014|[geoa]|["DR"-tx-15-"Dr"-noun-0,"DR"-tx-4-"Dr"-noun-0]|TX|2866/2;1373/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|32.31|Glipizide|C0017642|[orch,phsu]|["GLIPIZIDE"-tx-18-"glipizide"-noun-0,"GLIPIZIDE"-tx-2-"GLIPIZIDE"-noun-0]|TX|3024/9;531/9|D02.886.590.795.500
00000000|MMI|30.42|Citrus paradisi|C0947567|[plnt]|["grapefruit"-tx-2-"grapefruit"-noun-0]|TX|935/10|B01.650.940.800.575.100.875.177.538
00000000|MMI|30.23|Diet therapy|C0012159|[hlca]|["Diet"-tx-4-"DIET"-noun-0]|TX|[1193/4],[1227/4],[1294/4]|E02.642.249
00000000|MMI|29.64|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-18-"Pt"-noun-0,"PT"-tx-15-"Pt"-noun-0,"PT"-tx-13-"pt"-noun-0,"PT"-tx-12-"Pt's"-noun-0,"PT"-tx-11-"PT"-noun-0,"PT"-tx-9-"Pt"-noun-0,"PT"-tx-8-"Pt"-noun-0]|TX|3038/2;2851/2;2729/2;2656/4;2615/2;2526/2;2235/2|
00000000|MMI|29.64|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-18-"Pt"-noun-0,"PT"-tx-15-"Pt"-noun-0,"PT"-tx-13-"pt"-noun-0,"PT"-tx-12-"Pt's"-noun-0,"PT"-tx-11-"PT"-noun-0,"PT"-tx-9-"Pt"-noun-0,"PT"-tx-8-"Pt"-noun-0]|TX|3038/2;2851/2;2729/2;2656/4;2615/2;2526/2;2235/2|
00000000|MMI|27.26|Simvastatin|C0074554|[orch,phsu]|["SIMVASTATIN"-tx-2-"SIMVASTATIN"-noun-0]|TX|868/11|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|26.85|Oral|C0442027|[spco]|["PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|1187/2;1023/2;[395/2],[434/2],[686/2],[820/2],[888/2]|
00000000|MMI|26.14|Panama|C0030266|[geoa]|["PM"-tx-21-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|3439/2;158/2|Z01.107.169.772
00000000|MMI|25.98|Physicians|C0031831|[prog]|["DR"-tx-15-"Dr"-noun-0,"DR"-tx-4-"Dr"-noun-0]|TX|2866/2;1373/2|M01.526.485.810;N02.360.810
00000000|MMI|25.98|Cardiology discipline|C0007189|[bmod]|["Cardiology"-tx-15-"Cardiology"-noun-0,"Cardiology"-tx-4-"Cardiology"-noun-0]|TX|2918/10;1399/10|H02.403.429.163
00000000|MMI|25.93|Costa Rica|C0010182|[geoa]|["CRI"-tx-19-"CRI"-noun-0,"CRI"-tx-16-"CRI"-noun-0]|TX|3210/3;2937/3|Z01.107.169.238
00000000|MMI|25.60|Diurese|C0719972|[orch,phsu]|["Diurese"-tx-11-"diuresed"-verb-0]|TX|2618/8|D02.886.590.700.135.261.476.716;D02.886.655.500.261.476.716;D03.438.174.261.476.716
00000000|MMI|24.11|Surgical aspects|C0038895|[ftcn]|["operations"-tx-4-"OPERATIONS"-noun-0]|TX|1847/10|x.x.x.x.x.x.x
00000000|MMI|24.11|Walking (activity)|C0080331|[dora]|["Walking"-tx-4-"Walking"-noun-0]|TX|1324/7|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|22.47|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-13-"ASA"-noun-0]|TX|2774/3|D08.811.277.352.827.070.250
00000000|MMI|22.39|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-4-"Treatment"-noun-0]|TX|1633/9|x.x.x.x.x.x.x
00000000|MMI|22.36|Talpidae|C0324740|[mamm]|["Mole"-tx-18-"mole"-noun-0]|TX|3065/4|B01.050.150.900.649.473.450
00000000|MMI|20.98|Disease|C0012634|[dsyn]|["condition"-tx-20-"CONDITION"-noun-0,"condition"-tx-4-"Conditions"-noun-0]|TX|3323/9;1581/10|C23.550.288
00000000|MMI|20.95|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-2-"FUROSEMIDE"-noun-0]|TX|506/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|20.95|Hypercholesterolemia|C0020443|[dsyn]|["Elevated Cholesterol"-tx-4-"elevated cholesterol"-noun-0]|TX|1752/20|C18.452.584.500.500.396
00000000|MMI|20.95|Metoprolol|C0025859|[orch,phsu]|["METOPROLOL"-tx-3-"METOPROLOL"-noun-0]|TX|989/10|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|20.56|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-3-"Instruction"-noun-0,"Instruction"-tx-2-"Instruction"-noun-0]|TX|1051/11;[463/11],[917/11]|I02.903
00000000|MMI|19.57|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-21-"DISCHARGE"-noun-0,"Discharge"-tx-20-"DISCHARGE"-verb-0,"Discharge"-tx-4-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|3456/9;3313/9;1471/9;332/9;33/9|
00000000|MMI|19.57|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-21-"DISCHARGE"-noun-0,"Discharge"-tx-20-"DISCHARGE"-verb-0,"Discharge"-tx-4-"DISCHARGE"-noun-0,"Discharge"-tx-2-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|3456/9;3313/9;1471/9;332/9;33/9|
00000000|MMI|19.53|Congestive heart failure|C0018802|[dsyn]|["CHF"-tx-9-"CHF"-noun-0,"CHF"-tx-4-"CHF"-noun-0,"CHF"-tx-4-"CHF"-noun-1,"CONGESTIVE HEART FAILURE"-tx-4-"congestive heart failure"-noun-0]|TX|2542/3;[1457/3],[1814/3];[1457/3],[1814/3];[1540/24],[1820/24]|
00000000|MMI|19.49|Renal Cell Carcinoma|C0007134|[neop]|["Renal Cell Cancer"-tx-4-"renal cell cancer"-noun-0]|TX|1648/17|C04.557.470.200.025.390;C04.588.945.947.535.160;C12.758.820.750.160;C12.777.419.473.160;C13.351.937.820.535.160;C13.351.968.419.473.160
00000000|MMI|19.40|Mitomycin|C0002475|[antb,orch]|["MMC"-tx-4-"MMC"-noun-0]|TX|1385/3|D02.806.400.249.350;D03.383.097.500.350;D03.438.473.412.249.350
00000000|MMI|19.36|Meal (occasion for eating)|C1998602|[dora]|["Meals"-tx-3-"meals"-noun-0]|TX|1086/5|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|19.36|Troponin I|C0077401|[aapp,bacs]|["TnI"-tx-4-"TnI"-noun-0]|TX|2043/3|D05.750.078.730.825.925;D12.776.210.500.910.925;D12.776.220.525.825.925
00000000|MMI|19.33|Biopsy|C0005558|[diap]|["Bx"-tx-18-"bx"-noun-0]|TX|3070/2|E01.370.225.500.384.100;E01.370.225.998.054;E01.370.388.100;E04.074;E05.200.500.384.100;E05.200.998.054;E05.242.384.100
00000000|MMI|19.31|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|197/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|19.19|Angina Pectoris|C0002962|[fndg]|["anginas"-tx-7-"anginal"-adj-1]|TX|2220/7|C10.597.617.192.500;C14.280.647.187;C14.907.585.187;C23.888.592.612.233.500
00000000|MMI|18.15|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-4-"MG"-noun-0,"Mg++"-tx-3-"MG"-noun-0,"Mg++"-tx-2-"MG"-noun-0]|TX|1184/2;1020/2;[392/2],[431/2],[885/2]|
00000000|MMI|18.15|Milligram percent|C1960952|[qnco]|["mg %"-tx-4-"MG"-noun-0,"mg %"-tx-3-"MG"-noun-0,"mg %"-tx-2-"MG"-noun-0]|TX|1184/2;1020/2;[392/2],[431/2],[885/2]|
00000000|MMI|18.15|mg/dL|C0439269|[qnco]|["mg%"-tx-4-"MG"-noun-0,"mg%"-tx-3-"MG"-noun-0,"mg%"-tx-2-"MG"-noun-0]|TX|1184/2;1020/2;[392/2],[431/2],[885/2]|
00000000|MMI|17.80|Milk (body substance)|C0026131|[bdsu]|["MILK"-tx-2-"milk"-noun-0]|TX|481/4|A12.200.455;G07.203.100.700;G07.203.300.350.525;J02.200.700;J02.500.350.525
00000000|MMI|17.80|Nocturia|C0028734|[dsyn]|["NOCTURIA"-tx-4-"nocturia"-noun-0]|TX|2097/8|C23.888.942.343.550
00000000|MMI|16.34|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-4-"Low fat DIET"-noun-0]|TX|1241/3,1259/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|16.30|Compliance behavior|C1321605|[inbe]|["COMPLIANCE"-tx-5-"compliance"-noun-0]|TX|2119/10|F01.145.488.500;N05.300.150.600.600
00000000|MMI|16.25|Creatinine|C0010294|[bacs,orch]|["CREATININE"-tx-19-"creatinine"-noun-0]|TX|3168/10|D03.383.129.308.207
00000000|MMI|16.25|Electrocardiogram|C0013798|[fndg]|["EKG"-tx-9-"EKG"-noun-0]|TX|2435/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|16.25|Electrocardiography|C1623258|[diap]|["EKG"-tx-9-"EKG"-noun-0]|TX|2435/3|E01.370.370.380.240;E01.370.405.240
00000000|MMI|16.18|Echocardiography|C0013516|[diap]|["ECHOCARDIOGRAM"-tx-14-"echocardiogram"-noun-0]|TX|2812/14|E01.370.350.130.750;E01.370.350.850.220;E01.370.370.380.220
00000000|MMI|16.16|Ivory Coast|C0022326|[geoa]|["IV"-tx-11-"IV"-noun-0]|TX|2632/2|Z01.058.290.190.272
00000000|MMI|16.16|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-13-"regimen"-noun-0]|TX|2763/7|E02.183;N05.715.360.775.225
00000000|MMI|16.12|Antacids|C0003138|[phsu]|["Antacid"-tx-2-"antacid"-noun-0]|TX|490/7|D27.505.519.170;D27.505.954.483.080
00000000|MMI|16.12|Anti-Ulcer Agent|C0003216|[phsu]|["Antacid"-tx-2-"antacid"-noun-0]|TX|490/7|D27.505.954.483.203
00000000|MMI|16.12|Latvia|C0023128|[geoa]|["LV"-tx-6-"LV"-noun-0]|TX|2165/2|Z01.542.248.136.560;Z01.586.950.140.560
00000000|MMI|16.10|Potassium Chloride|C0032825|[inch,phsu]|["POTASSIUM CHLORIDE"-tx-2-"POTASSIUM CHLORIDE"-noun-0]|TX|758/18|D01.210.450.150.750;D01.745.625
00000000|MMI|15.79|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-20-"M.D"-noun-0,"M.D."-tx-2-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|3409/3;646/3;274/3|
00000000|MMI|15.79|Override|C1547671|[acty]|["Override"-tx-2-"Override"-verb-0,"Override"-tx-2-"override"-verb-0]|TX|[577/8],[594/8];788/8|
00000000|MMI|15.41|Order (action)|C1705178|[acty]|["Order"-tx-21-"ORDERS"-verb-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3466/6;654/5;201/5;43/6|
00000000|MMI|15.41|Order (arrangement)|C1705176|[qlco]|["Order"-tx-21-"ORDERS"-verb-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3466/6;654/5;201/5;43/6|
00000000|MMI|15.41|Order (document)|C1705175|[inpr]|["Order"-tx-21-"ORDERS"-verb-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3466/6;654/5;201/5;43/6|
00000000|MMI|15.41|Order (taxonomic)|C1705177|[clas]|["Order"-tx-21-"ORDERS"-verb-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3466/6;654/5;201/5;43/6|
00000000|MMI|15.41|Permutation|C1882348|[qlco]|["Order"-tx-21-"ORDERS"-verb-0,"Order"-tx-2-"order"-noun-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3466/6;654/5;201/5;43/6|
00000000|MMI|15.41|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-21-"ORDERS"-verb-0,"ORDER"-tx-2-"order"-noun-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|3466/6;654/5;201/5;43/6|
00000000|MMI|15.27|Total nephrectomy|C0176996|[topp]|["Nephrectomy"-tx-16-"nephrectomy"-noun-0,"Nephrectomy"-tx-4-"nephrectomy"-noun-0]|TX|2945/11;[1687/11],[1705/11],[2002/11]|
00000000|MMI|14.85|Hospital admission|C0184666|[hlca]|["Admission"-tx-9-"admission"-adj-0,"admitted"-tx-9-"admitted"-verb-0,"Admission"-tx-4-"Admission"-noun-0,"Admit"-tx-4-"ADMIT"-verb-0]|TX|2349/9;2529/8;1528/9;1440/5|
00000000|MMI|14.75|Continuous|C0549178|[idcn]|["Continued"-tx-18-"continued"-verb-0,"ONGOING"-tx-18-"ongoing"-adj-0,"Continued"-tx-13-"continued"-verb-0,"Continued"-tx-12-"continued"-verb-0]|TX|3041/9;3097/7;2732/9;2703/9|
00000000|MMI|14.64|Creatine|C0010286|[aapp,bacs]|["CREATINE"-tx-17-"Creatine"-noun-0]|TX|2966/8|D02.078.370.280;D12.125.373
00000000|MMI|14.64|Endometriosis|C0014175|[dsyn]|["Endo"-tx-18-"Endo"-adj-0]|TX|3003/4|C13.351.500.163
00000000|MMI|14.64|Myocardial Infarction|C0027051|[dsyn]|["Infarction, Myocardial"-tx-4-"myocardial infarction"-noun-0]|TX|1790/21|C14.280.647.500;C14.907.585.500
00000000|MMI|14.64|clopidogrel|C0070166|[orch,phsu]|["CLOPIDOGREL"-tx-4-"CLOPIDOGREL"-noun-0]|TX|1167/11|x.x.x.x
00000000|MMI|14.64|ferrous sulfate|C0060282|[inch,phsu]|["Ferrous sulphate"-tx-2-"FERROUS SULFATE"-noun-0]|TX|409/15|x.x.x.x
00000000|MMI|14.24|Daily|C0332173|[tmco]|["QD"-tx-4-"QD"-noun-0,"QD"-tx-3-"QD"-noun-0,"QD"-tx-2-"QD"-noun-0]|TX|1190/2;1026/2;[398/2],[528/2]|
00000000|MMI|13.24|Home visit (procedure)|C0020043|[hlca]|["home services"-tx-2-"Home services"-noun-0]|TX|315/4,323/8|N04.452.758.307
00000000|MMI|13.14|Biomechanical compliance|C0009563|[qnco]|["Compliance"-tx-5-"compliance"-noun-0]|TX|2119/10|G01.374.590.210
00000000|MMI|13.14|Compliance|C3714738|[fndg]|["Compliance"-tx-5-"compliance"-noun-0]|TX|2119/10|G01.374.590.210
00000000|MMI|13.09|Christmas Island|C0006888|[geoa]|["CXR"-tx-9-"CXR"-noun-0]|TX|2396/3|Z01.639.100;Z01.678.100.373
00000000|MMI|13.08|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-20-"PLAN"-noun-0]|TX|3347/4|C10.228.140.744
00000000|MMI|13.03|ECHO protocol|C0058928|[topp]|["ECHO"-tx-6-"Echo"-noun-0]|TX|2131/4|x.x.x.x
00000000|MMI|13.03|Rabbi|C0684010|[prog]|["R."-tx-4-"R"-noun-0]|TX|1918/1|M01.526.799.500
00000000|MMI|13.03|Stomach|C0038351|[bpoc]|["STOMACH"-tx-3-"stomach"-noun-0]|TX|1104/7|A03.556.875.875
00000000|MMI|13.02|Brunei|C0006320|[geoa]|["BX"-tx-18-"bx"-noun-0]|TX|3070/2|Z01.252.145.130
00000000|MMI|13.01|phosphoethanolamine|C0070939|[bacs,orch]|["PE"-tx-9-"PE"-noun-0]|TX|2359/2|x.x.x.x
00000000|MMI|13.00|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|197/3|E04.157.310;E04.950.300.299
00000000|MMI|12.98|IFIH1 protein, human|C1310463|[aapp,enzy]|["MDA-5"-tx-2-"mda 5"-noun-0]|TX|798/3,829/1|x.x.x.x
00000000|MMI|12.94|Oxygen|C0030054|[elii,phsu]|["O2"-tx-9-"O2"-noun-0]|TX|2330/2|D01.268.185.550;D01.362.670;x.x.x.x
00000000|MMI|12.94|Solomon Islands|C0037623|[geoa]|["BP"-tx-9-"BP"-noun-0]|TX|2309/2|Z01.639.760.590
00000000|MMI|12.93|Sodium|C0037473|[bacs,elii]|["SODIUM"-tx-4-"Sodium"-noun-0]|TX|1307/6|D01.268.549.750;D01.268.557.650;D01.552.528.850;D01.552.547.725;x.x.x.x
00000000|MMI|12.93|PO-2|C0297199|[orch]|["PO-2"-tx-2-"PO 2"-noun-0]|TX|525/2,541/1|x.x.x.x
00000000|MMI|12.90|Automobiles|C0004381|[mnob]|["Car"-tx-1-"CAR"-noun-0]|TX|115/3|J01.937.500.100
00000000|MMI|12.90|elongation factor DmS-II|C0378717|[aapp]|["dm ii"-tx-4-"DM II"-noun-0]|TX|1978/5|x.x.x.x
00000000|MMI|12.89|Evaluation|C0220825|[hlca]|["Evaluation"-tx-14-"evaluation"-noun-0]|TX|2839/10|E05.337;N05.715.360.335
00000000|MMI|12.89|Nevus|C0027960|[neop]|["Mole"-tx-18-"mole"-noun-0]|TX|3065/4|C04.557.665.560
00000000|MMI|12.89|BaseLine dental cement|C0168634|[bodm]|["baseline"-tx-17-"baseline"-noun-0]|TX|2985/8|x.x.x.x
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-4-"Complications"-noun-0]|TX|1607/13|x.x.x
00000000|MMI|11.49|Kidney|C0022646|[bpoc]|["Renal"-tx-16-"Renal"-adj-0]|TX|2930/5|A05.810.453
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-4-"PROCEDURES"-noun-0]|TX|1862/10|x.x.x
00000000|MMI|11.01|Basal Diet|C2983588|[food]|["DIET"-tx-4-"DIET"-noun-0]|TX|[1193/4],[1227/4],[1294/4]|
00000000|MMI|11.01|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-4-"DIET"-noun-0]|TX|[1193/4],[1227/4],[1294/4]|
00000000|MMI|11.01|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-4-"DIET"-noun-0]|TX|[1193/4],[1227/4],[1294/4]|
00000000|MMI|10.95|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-3-"Instruction"-noun-0,"Instruction"-tx-2-"Instruction"-noun-0]|TX|1051/11;[463/11],[917/11]|
00000000|MMI|10.95|Instructions|C1442085|[idcn]|["instruction"-tx-3-"Instruction"-noun-0,"instruction"-tx-2-"Instruction"-noun-0]|TX|1051/11;[463/11],[917/11]|
00000000|MMI|10.78|Admission activity|C0809949|[hlca]|["Admission"-tx-9-"admission"-adj-0,"Admitted"-tx-9-"admitted"-verb-0,"Admission"-tx-4-"Admission"-noun-0]|TX|2349/9;2529/8;1528/9|
00000000|MMI|10.61|Code|C0805701|[inpr]|["CODE"-tx-20-"CODE"-noun-0,"CODE"-tx-2-"CODE"-noun-0,"CODE"-tx-2-"code"-noun-0]|TX|3234/4;279/4;297/4|
00000000|MMI|10.61|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-20-"CODE"-noun-0,"Code"-tx-2-"CODE"-noun-0,"Code"-tx-2-"code"-noun-0]|TX|3234/4;279/4;297/4|
00000000|MMI|10.49|/40|C0439509|[tmco]|["/40"-tx-6-"40"-integer-0,"/40"-tx-2-"40"-integer-0]|TX|2160/2;[519/2],[882/2]|
00000000|MMI|10.49|40%|C3842587|[qnco]|["40%"-tx-6-"40"-integer-0,"40%"-tx-2-"40"-integer-0]|TX|2160/2;[519/2],[882/2]|
00000000|MMI|10.42|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-4-"DIAGNOSIS"-noun-0,"DIAGNOSIS"-tx-4-"DIAGNOSIS"-noun-1]|TX|[1446/9],[1571/9];[1446/9],[1571/9]|E01
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-4-"DIAGNOSIS"-noun-0]|TX|[1446/9],[1571/9]|
00000000|MMI|10.42|Recommendation|C0034866|[idcn]|["recommend"-tx-18-"Recommend"-verb-0,"recommend"-tx-14-"Recommend"-verb-0]|TX|3081/9;2796/9|
00000000|MMI|10.42|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-21-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|3466/6;43/6|
00000000|MMI|9.99|Pathological Dilatation|C0012359|[patf]|["Dilation"-tx-6-"dilation"-noun-0]|TX|2168/8|C23.300.325
00000000|MMI|9.99|utilization qualifier|C0042153|[ftcn]|["use"-tx-19-"use"-noun-0]|TX|3224/3|x.x.x
00000000|MMI|9.94|Appointments|C0003629|[idcn]|["Appointment"-tx-4-"APPOINTMENT"-noun-0]|TX|1355/11|N04.452.095
00000000|MMI|9.86|Universities|C0041740|[mnob,orgt]|["University"-tx-15-"University"-noun-0]|TX|2901/10|I02.783.830
00000000|MMI|9.74|Back|C0004600|[blor]|["BACK"-tx-18-"back"-adj-0]|TX|3076/4|A01.923.176
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-4-"Infections"-noun-0]|TX|1594/10|C01.539
00000000|MMI|8.28|Condition|C0348080|[qlco]|["Condition"-tx-20-"CONDITION"-noun-0,"Condition"-tx-4-"Conditions"-noun-0]|TX|3323/9;1581/10|
00000000|MMI|8.28|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-20-"CONDITION"-noun-0,"Condition"-tx-4-"Conditions"-noun-0]|TX|3323/9;1581/10|
00000000|MMI|8.28|Logical Condition|C1705253|[cnce]|["Condition"-tx-20-"CONDITION"-noun-0,"Condition"-tx-4-"Conditions"-noun-0]|TX|3323/9;1581/10|
00000000|MMI|7.70|Plavix|C0633084|[orch,phsu]|["Plavix"-tx-13-"Plavix"-noun-0,"Plavix"-tx-4-"PLAVIX"-noun-0]|TX|2788/6;1158/6|
00000000|MMI|7.53|Myocardial Infarction ECG Assessment|C3810814|[diap]|["MI"-tx-10-"MI"-noun-0,"Myocardial Infarction"-tx-4-"myocardial infarction"-noun-0]|TX|2574/2;1790/21|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-20-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|3365/7;226/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-20-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|3365/7;226/7|
00000000|MMI|7.24|Cardiac enzymes|C0443763|[aapp,enzy]|["Cardiac enzymes"-tx-10-"cardiac enzymes"-noun-0,"Cardiac enzymes"-tx-9-"cardiac enzymes"-noun-0]|TX|2598/15;2470/15|
00000000|MMI|7.24|day|C0439228|[tmco]|["DAYS"-tx-4-"days"-noun-0,"DAYS"-tx-2-"Days"-noun-0]|TX|2072/4;831/4|
00000000|MMI|7.21|30%|C3842588|[fndg]|["30%"-tx-21-"30"-fraction-0,"30%"-tx-1-"30"-fraction-0]|TX|3425/2;143/2|
00000000|MMI|7.19|10%|C3842590|[fndg]|["10%"-tx-4-"10"-integer-0,"10%"-tx-2-"10"-fraction-0]|TX|1155/2;855/2|
00000000|MMI|7.12|Hospital course|C0489547|[fndg]|["Hospital course"-tx-9-"HOSPITAL COURSE"-noun-0,"Hospital course"-tx-4-"HOSPITAL COURSE"-noun-1]|TX|2505/15;1944/15|
00000000|MMI|7.12|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-9-"HOSPITAL COURSE"-noun-0,"Hospital course"-tx-4-"HOSPITAL COURSE"-noun-0]|TX|2505/15;1944/15|
00000000|MMI|7.11|Negative|C0205160|[qlco]|["Negative"-tx-10-"negative"-adj-0,"Negative"-tx-9-"negative"-noun-0]|TX|2582/8;2486/8|
00000000|MMI|7.11|Negative - answer|C3853545|[qlco]|["Negative"-tx-10-"negative"-adj-0,"Negative"-tx-9-"negative"-noun-0]|TX|2582/8;2486/8|
00000000|MMI|7.11|Negative Charge|C2825491|[qlco]|["Negative"-tx-10-"negative"-adj-0,"Negative"-tx-9-"negative"-noun-0]|TX|2582/8;2486/8|
00000000|MMI|7.11|Negative Finding|C1513916|[fndg]|["NEGATIVE"-tx-10-"negative"-adj-1,"NEGATIVE"-tx-9-"negative"-noun-0]|TX|2582/8;2486/8|
00000000|MMI|7.11|Negative Number|C2825415|[cnce]|["Negative"-tx-10-"negative"-adj-0,"Negative"-tx-9-"negative"-noun-0]|TX|2582/8;2486/8|
00000000|MMI|7.11|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-21-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|3439/2;158/2|
00000000|MMI|7.09|effusion|C0013687|[patf]|["EFFUSIONS"-tx-9-"effusions"-noun-0]|TX|[2373/9],[2407/9]|
00000000|MMI|7.05|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-20-"Stable"-adj-0,"Stable"-tx-17-"stable"-adj-0]|TX|3334/6;2975/6|
00000000|MMI|7.05|Stable status|C0205360|[qlco]|["STABLE"-tx-20-"Stable"-adj-0,"STABLE"-tx-17-"stable"-adj-0]|TX|3334/6;2975/6|
00000000|MMI|7.04|20%|C3842589|[fndg]|["20%"-tx-12-"20"-integer-0,"20%"-tx-2-"20"-integer-0]|TX|2688/2;565/2|
00000000|MMI|6.98|Full|C0443225|[qlco]|["Full"-tx-20-"FULL"-adj-0,"Full"-tx-2-"Full"-adj-0]|TX|3229/4;292/4|
00000000|MMI|6.97|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-9-"sat"-noun-0,"SAT"-tx-4-"sat"-noun-0]|TX|2333/3;1254/3|
00000000|MMI|6.97|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-9-"sat"-noun-0,"SAT"-tx-4-"sat"-noun-0]|TX|2333/3;1254/3|
00000000|MMI|6.95|Home environment|C0442519|[cnce]|["house"-tx-4-"House"-noun-0]|TX|[1233/5],[1269/5]|
00000000|MMI|6.95|House (environment)|C2003847|[mnob]|["House"-tx-4-"House"-noun-0]|TX|[1233/5],[1269/5]|
00000000|MMI|6.95|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-15-"Dr"-noun-0,"DR"-tx-4-"Dr"-noun-0]|TX|2866/2;1373/2|
00000000|MMI|6.95|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-15-"Dr"-noun-0,"DR"-tx-4-"Dr"-noun-0]|TX|2866/2;1373/2|
00000000|MMI|6.95|Doctor - Title|C2348314|[cnce]|["Dr."-tx-15-"Dr"-noun-0,"Dr."-tx-4-"Dr"-noun-0]|TX|2866/2;1373/2|
00000000|MMI|6.94|Cardiology service|C3887620|[hcro]|["Cardiology"-tx-15-"Cardiology"-noun-0,"Cardiology"-tx-4-"Cardiology"-noun-0]|TX|2918/10;1399/10|
00000000|MMI|6.90|Complete Response with Incomplete Bone Marrow Recovery|C3538993|[fndg]|["CRi"-tx-19-"CRI"-noun-0,"CRi"-tx-16-"CRI"-noun-0]|TX|3210/3;2937/3|
00000000|MMI|6.90|Cranial Rhythmic Impulse|C1704519|[phsf]|["CRI"-tx-19-"CRI"-noun-0,"CRI"-tx-16-"CRI"-noun-0]|TX|3210/3;2937/3|
00000000|MMI|6.90|RNH1 gene|C1826843|[gngm]|["CRI"-tx-19-"CRI"-noun-0,"CRI"-tx-16-"CRI"-noun-0]|TX|3210/3;2937/3|
00000000|MMI|6.89|Conventional (Clear Cell) Renal Cell Carcinoma|C0279702|[neop]|["RCC"-tx-16-"RCC"-noun-0,"RCC"-tx-4-"RCC"-noun-0]|TX|2961/3;2018/3|
00000000|MMI|6.83|Dilate procedure|C1322279|[topp]|["Dilation"-tx-6-"dilation"-noun-0]|TX|2168/8|E05.284
00000000|MMI|6.71|Electrolytes|C0013832|[inch,phsu]|["ELECTROLYTES"-tx-19-"electrolytes"-noun-0]|TX|3183/12|D01.248
00000000|MMI|6.70|Heart|C0018787|[bpoc]|["Cardiac"-tx-13-"cardiac"-adj-0]|TX|2755/7|A07.541
00000000|MMI|6.62|Periodicals|C0031082|[inpr]|["serial"-tx-10-"serial"-adj-0]|TX|2591/6|V02.690
00000000|MMI|5.18|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-4-"OPERATIONS"-noun-0]|TX|1847/10|
00000000|MMI|5.18|Affecting|C0392760|[ftcn]|["Affecting"-tx-4-"affecting"-verb-0]|TX|1623/9|
00000000|MMI|5.18|Approximate|C0332232|[qlco]|["Approximate"-tx-4-"approximate"-adj-0]|TX|1140/11|
00000000|MMI|5.18|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-4-"CAD"-noun-0]|TX|1986/3|
00000000|MMI|5.18|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-9-"CV"-noun-0]|TX|2522/2|
00000000|MMI|5.18|Clinical Trial Final Report|C3889645|[inpr]|["Reports"-tx-5-"Reports"-verb-0]|TX|2107/7|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-4-"Complications"-noun-0]|TX|1607/13|
00000000|MMI|5.18|Cow's milk|C0349374|[food]|["Milk"-tx-2-"milk"-noun-0]|TX|481/4|
00000000|MMI|5.18|Deny (action)|C2700401|[acty]|["Deny"-tx-7-"Denies"-verb-0]|TX|2205/6|
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Electrocardiogram: myocardial infarction (finding)|C0428953|[lbtr]|["MYOCARDIAL INFARCTION"-tx-4-"myocardial infarction"-noun-0]|TX|1790/21|
00000000|MMI|5.18|Fluid restriction|C0204700|[topp]|["Fluid restriction"-tx-4-"Fluid restriction"-noun-0]|TX|1199/17|
00000000|MMI|5.18|GRAPEFRUIT EXTRACT|C0440280|[orch,phsu]|["GRAPEFRUIT"-tx-2-"grapefruit"-noun-0]|TX|935/10|
00000000|MMI|5.18|Grapefruit (food)|C0995150|[food]|["GRAPEFRUIT"-tx-2-"grapefruit"-noun-0]|TX|935/10|
00000000|MMI|5.18|Grapefruit Flavor|C1365950|[food]|["GRAPEFRUIT"-tx-2-"grapefruit"-noun-0]|TX|935/10|
00000000|MMI|5.18|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-4-"OPERATIONS"-noun-0]|TX|1847/10|
00000000|MMI|5.18|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-4-"hypertension"-noun-0]|TX|1725/12|
00000000|MMI|5.18|III (suffix)|C1705160|[qlco]|["III"-tx-9-"III"-noun-0]|TX|2456/3|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-4-"PROCEDURES"-noun-0]|TX|1862/10|
00000000|MMI|5.18|Involvement with|C1314939|[ftcn]|["Affecting"-tx-4-"affecting"-verb-0]|TX|1623/9|
00000000|MMI|5.18|MANEA gene|C1427293|[gngm]|["ENDO"-tx-18-"Endo"-adj-0]|TX|3003/4|
00000000|MMI|5.18|Malignant neoplasm of kidney|C0740457|[neop]|["Renal Cancer"-tx-4-"renal cancer"-noun-0]|TX|1668/12|
00000000|MMI|5.18|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|342/11|
00000000|MMI|5.18|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|342/11|
00000000|MMI|5.18|Milk - dietary|C2825079|[food]|["MILK"-tx-2-"milk"-noun-0]|TX|481/4|
00000000|MMI|5.18|Milk Specimen|C0444318|[sbst]|["Milk"-tx-2-"milk"-noun-0]|TX|481/4|
00000000|MMI|5.18|Myocardial infarction:Finding:Point in time:^Patient:Ordinal|C2926063|[clna]|["Myocardial infarction"-tx-4-"myocardial infarction"-noun-0]|TX|1790/21|
00000000|MMI|5.18|NPPA gene|C1417807|[gngm]|["PND"-tx-4-"PND"-noun-0]|TX|2091/3|
00000000|MMI|5.18|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|177/14|
00000000|MMI|5.18|Orthopnea|C0085619|[sosy]|["Orthopnoea"-tx-4-"orthopnea"-noun-0]|TX|2079/9|
00000000|MMI|5.18|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|177/14|
00000000|MMI|5.18|Paroxysmal nocturnal dyspnea|C1956415|[dsyn]|["PND"-tx-4-"PND"-noun-0]|TX|2091/3|
00000000|MMI|5.18|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-2-"MEDICATIONS"-noun-0]|TX|342/11|D26
00000000|MMI|5.18|Positive|C1446409|[qlco]|["ruled"-tx-10-"Ruled"-verb-0]|TX|2560/5|
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-4-"PROCEDURES"-noun-0]|TX|1862/10|
00000000|MMI|5.18|Regulatory Report|C3273238|[inpr]|["Report"-tx-5-"Reports"-verb-0]|TX|2107/7|
00000000|MMI|5.18|Renal carcinoma|C1378703|[neop]|["Renal Cancer"-tx-4-"renal cancer"-noun-0]|TX|1668/12|
00000000|MMI|5.18|Report (document)|C0684224|[inpr]|["Reports"-tx-5-"Reports"-verb-0]|TX|2107/7|
00000000|MMI|5.18|Reporting|C0700287|[hlca]|["reports"-tx-5-"Reports"-verb-0]|TX|2107/7|
00000000|MMI|5.18|Requirement|C1514873|[ftcn]|["Required"-tx-4-"Required"-verb-0]|TX|1129/8|
00000000|MMI|5.18|Roman Numeral III|C0439070|[inpr]|["III"-tx-9-"III"-noun-0]|TX|2456/3|
00000000|MMI|5.18|S prime|C2603362|[clna]|["S'"-tx-4-"("-noun-0]|TX|1366/1|
00000000|MMI|5.18|Take|C1515187|[hlca]|["Take"-tx-3-"Take"-verb-0]|TX|1063/4|
00000000|MMI|5.18|Today|C0310367|[antb,orch]|["Today"-tx-2-"Today"-noun-0]|TX|845/5|
00000000|MMI|5.18|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-2-"Today"-noun-0]|TX|845/5|
00000000|MMI|5.18|per second|C0565930|[qnco]|["/s"-tx-4-"("-noun-0]|TX|1366/1|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-4-"TREATMENTS/PROCEDURES"-noun-0]|TX|1885/21|
00000000|MMI|4.12|Known allergy|C3845888|[fndg]|["Known allergy"-tx-4-"Known Allergies"-noun-1]|TX|1424/15|
00000000|MMI|4.12|Medical problem:Finding:Point in time:^Patient:Nominal|C1715372|[clna]|["Medical problem"-tx-20-"medical problems"-noun-0]|TX|3296/16|
00000000|MMI|4.12|Patient Problem|C1254481|[fndg]|["Medical Problem"-tx-20-"medical problems"-noun-0]|TX|3296/16|
00000000|MMI|3.98|Beginning|C0439659|[tmco]|["Start"-tx-2-"Starting"-verb-0]|TX|836/8|
00000000|MMI|3.72|Treated with|C0332293|[topp]|["Treated with"-tx-8-"treated with"-verb-0]|TX|2270/12|
00000000|MMI|3.70|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-4-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1461/9,1481/9|
00000000|MMI|3.70|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-4-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1461/9,1481/9|
00000000|MMI|3.68|+5|C0728893|[qnco]|["+5"-tx-2-"5"-fraction-0]|TX|853/1|
00000000|MMI|3.68|70%|C3842584|[fndg]|["70%"-tx-9-"70's"-noun-0]|TX|2323/4|
00000000|MMI|3.68|>5|C0439084|[qnco]|[">5"-tx-2-"5"-fraction-0]|TX|853/1|
00000000|MMI|3.68|ALYREF gene|C1425988|[gngm]|["REF"-tx-2-"ref"-noun-0]|TX|691/3|
00000000|MMI|3.68|Additional comments|C1830770|[fndg]|["Additional comments"-tx-20-"ADDITIONAL COMMENTS"-noun-0]|TX|3239/19|
00000000|MMI|3.68|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|239/9|
00000000|MMI|3.68|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|239/9|
00000000|MMI|3.68|Coating (film)|C1522408|[qlco]|["Coated"-tx-2-"COATED"-adj-0]|TX|379/6|
00000000|MMI|3.68|Dilated|C0700124|[fndg]|["Dilation"-tx-6-"dilation"-noun-0]|TX|2168/8|
00000000|MMI|3.68|Enteral|C1304890|[spco]|["Enteric"-tx-2-"ENTERIC"-adj-0]|TX|371/7|
00000000|MMI|3.68|Insufficiency|C0231179|[ftcn]|["Insufficiency"-tx-6-"insufficiency"-noun-0]|TX|2190/13|
00000000|MMI|3.68|Laboratory test finding|C0587081|[fndg]|["Labs"-tx-9-"Labs"-noun-0]|TX|2464/4|
00000000|MMI|3.68|Operational Compliance|C3244300|[idcn]|["compliance"-tx-5-"compliance"-noun-0]|TX|2119/10|
00000000|MMI|3.68|Status|C0449438|[qlco]|["Status"-tx-2-"STATUS"-noun-0]|TX|284/6|
00000000|MMI|3.68|Usage|C0457083|[ftcn]|["Use"-tx-19-"use"-noun-0]|TX|3224/3|
00000000|MMI|3.68|Use - dosing instruction imperative|C1947944|[inpr]|["Use"-tx-19-"use"-noun-0]|TX|3224/3|
00000000|MMI|3.68|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-4-"DISCHARGE DIAGNOSIS"-noun-1]|TX|1471/19|
00000000|MMI|3.65|Dose number|C1115464|[qnco]|["Dose number"-tx-4-"Number Doses"-noun-0]|TX|1113/6,1123/5|
00000000|MMI|3.65|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose number"-tx-4-"Number Doses"-noun-0]|TX|1113/6,1123/5|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-20-"ENTERED"-verb-0]|TX|3373/7|
00000000|MMI|3.63|Creatinine finding|C1561535|[fndg]|["Creatinine"-tx-19-"creatinine"-noun-0]|TX|3168/10|
00000000|MMI|3.63|Disposition|C0743223|[idcn]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|302/11|
00000000|MMI|3.63|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|302/11|
00000000|MMI|3.63|FABP6 protein, human|C1435727|[aapp,bacs]|["GT"-tx-9-"gt"-noun-0]|TX|2338/2|
00000000|MMI|3.63|Interaction|C1704675|[ftcn]|["Interaction"-tx-2-"INTERACTION"-noun-0]|TX|728/11|
00000000|MMI|3.63|November|C3828767|[tmco]|["November"-tx-4-"November"-noun-0]|TX|1410/8|
00000000|MMI|3.63|Plain chest X-ray|C0039985|[diap]|["cxr"-tx-9-"CXR"-noun-0]|TX|2396/3|
00000000|MMI|3.63|Vanadium 5+|C2349105|[elii]|["V5+"-tx-9-"V5"-noun-0]|TX|2444/2|
00000000|MMI|3.61|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-4-"ACTIVITY"-noun-0]|TX|1314/8|
00000000|MMI|3.61|Active|C0205177|[ftcn]|["Activity"-tx-4-"ACTIVITY"-noun-0]|TX|1314/8|
00000000|MMI|3.61|Activities|C0441655|[acty]|["ACTIVITY"-tx-4-"ACTIVITY"-noun-0]|TX|1314/8|
00000000|MMI|3.61|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-4-"ACTIVITY"-noun-0]|TX|1314/8|
00000000|MMI|3.61|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-4-"ACTIVITY"-noun-0]|TX|1314/8|
00000000|MMI|3.61|Percent Activity|C0439167|[qnco]|["% Activity"-tx-4-"ACTIVITY"-noun-0]|TX|1314/8|
00000000|MMI|3.61|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-4-"ACTIVITY"-noun-0]|TX|1314/8|
00000000|MMI|3.61|Planned|C1301732|[ftcn]|["Plan"-tx-20-"PLAN"-noun-0]|TX|3347/4|
00000000|MMI|3.61|Treatment Plan|C0599880|[inpr]|["Plan"-tx-20-"PLAN"-noun-0]|TX|3347/4|
00000000|MMI|3.59|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|106/7|
00000000|MMI|3.59|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|106/7|
00000000|MMI|3.59|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|106/7|
00000000|MMI|3.59|End|C0444930|[spco]|["End"-tx-21-"END"-noun-0]|TX|3449/3|
00000000|MMI|3.59|Out (direction)|C0439787|[spco]|["Out"-tx-10-"out"-adv-0]|TX|2566/3|
00000000|MMI|3.59|Presentation|C0449450|[idcn]|["Presented"-tx-8-"presented"-verb-0]|TX|2249/9|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-8-"PUO"-noun-0]|TX|2299/3|
00000000|MMI|3.59|Removed|C0849355|[qlco]|["Out"-tx-10-"out"-adv-0]|TX|2566/3|
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-4-"Responsible"-adj-1]|TX|1492/11|
00000000|MMI|3.59|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Return"-tx-20-"return"-noun-0]|TX|3267/6|
00000000|MMI|3.59|Send (transmission)|C1519246|[ftcn]|["Send"-tx-8-"send"-verb-0]|TX|2291/4|
00000000|MMI|3.59|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-21-"END"-noun-0]|TX|3449/3|
00000000|MMI|3.58|Dry body weight (observable entity)|C2709005|[orga]|["Dry weight"-tx-11-"dry weight"-noun-0]|TX|2644/10|
00000000|MMI|3.57|Advanced phase|C0205179|[qlco]|["Advanced"-tx-12-"advanced"-verb-0]|TX|2666/8|
00000000|MMI|3.57|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|161/10|
00000000|MMI|3.57|Echo (insect)|C1655045|[euka]|["Echo"-tx-6-"Echo"-noun-0]|TX|2131/4|
00000000|MMI|3.57|Empty (qualifier)|C1880497|[qlco]|["Empty"-tx-3-"empty"-adj-0]|TX|1098/5|
00000000|MMI|3.57|Entire stomach|C1278920|[bpoc]|["Stomach"-tx-3-"stomach"-noun-0]|TX|1104/7|
00000000|MMI|3.57|Gastric Tissue|C1517454|[tisu]|["STOMACH"-tx-3-"stomach"-noun-0]|TX|1104/7|
00000000|MMI|3.57|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-2-"Reason"-noun-0]|TX|777/6|
00000000|MMI|3.57|Negation|C1518422|[ftcn]|["Not"-tx-4-"NOT"-adv-0]|TX|1909/3|
00000000|MMI|3.57|R prime|C2603358|[clna]|["R'"-tx-4-"R"-noun-0]|TX|1918/1|
00000000|MMI|3.57|Right|C0205090|[spco]|["R-"-tx-4-"R"-noun-0]|TX|1918/1|
00000000|MMI|3.57|Stomach structure|C3714551|[bpoc]|["Stomach"-tx-3-"stomach"-noun-0]|TX|1104/7|
00000000|MMI|3.57|Subject Continuance|C2826258|[evnt]|["CONT"-tx-18-"cont"-noun-0]|TX|3016/4|
00000000|MMI|3.56|M-71|C0126575|[orch,phsu]|["M-71"-tx-4-"71 m"-noun-0]|TX|1961/2,1967/1|
00000000|MMI|3.56|Additional|C1524062|[ftcn]|["Added"-tx-2-"added"-verb-0]|TX|603/5|
00000000|MMI|3.56|Box Dosing Unit|C1706087|[qnco]|["BX"-tx-18-"bx"-noun-0]|TX|3070/2|
00000000|MMI|3.56|Echocardiogram (image)|C2243117|[inpr]|["Echocardiogram"-tx-14-"echocardiogram"-noun-0]|TX|2812/14|
00000000|MMI|3.56|Electrolyte [EPC]|C3536863|[phsu]|["Electrolytes"-tx-19-"electrolytes"-noun-0]|TX|3183/12|
00000000|MMI|3.55|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-4-"RESUME"-noun-0]|TX|1934/6|
00000000|MMI|3.55|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-4-"RESUME"-noun-0]|TX|1934/6|
00000000|MMI|3.55|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|210/4|
00000000|MMI|3.55|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-4-"RESUME"-noun-0]|TX|1934/6|
00000000|MMI|3.55|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-13-"ASA"-noun-0]|TX|2774/3|
00000000|MMI|3.55|Cardiac - anatomy qualifier|C1522601|[spco]|["Cardiac"-tx-13-"cardiac"-adj-0]|TX|2755/7|
00000000|MMI|3.55|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-13-"regimen"-noun-0]|TX|2763/7|
00000000|MMI|3.55|Remaining|C1527428|[qlco]|["Remaining"-tx-13-"remaining"-noun-0]|TX|2745/9|
00000000|MMI|3.53|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-4-"FOLLOW UP"-adj-0]|TX|1345/9|
00000000|MMI|3.53|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-1]|TX|197/3|
00000000|MMI|3.53|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|197/3|
00000000|MMI|3.53|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-4-"FOLLOW UP"-adj-0]|TX|1345/9|
00000000|MMI|3.53|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-4-"FOLLOW UP"-adj-0]|TX|1345/9|
00000000|MMI|3.53|Fourth sound gallop|C0425593|[fndg]|["S4 gallop"-tx-9-"S4 gallop"-noun-0]|TX|2386/9|
00000000|MMI|3.53|follow-up|C1522577|[hlca]|["Follow Up"-tx-4-"FOLLOW UP"-adj-0]|TX|1345/9|
00000000|MMI|3.52|IFIH1 gene|C1537399|[gngm]|["MDA-5"-tx-2-"mda 5"-noun-0]|TX|798/3,829/1|
00000000|MMI|3.52|IFIH1 wt Allele|C3888243|[gngm]|["MDA-5"-tx-2-"mda 5"-noun-0]|TX|798/3,829/1|
00000000|MMI|3.50|Antacid Effects|C1383090|[phsf]|["Antacid"-tx-2-"antacid"-noun-0]|TX|490/7|
00000000|MMI|3.50|C5orf38 gene|C1864832|[gngm]|["CEI"-tx-19-"CEi"-noun-0]|TX|3220/3|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-4-"Causing"-adj-0]|TX|1520/7|
00000000|MMI|3.50|Leucovorin Calcium|C0731033|[orch,phsu,vita]|["LV"-tx-6-"LV"-noun-0]|TX|2165/2|
00000000|MMI|3.50|Liposome Vesicle|C1881413|[chvs]|["LV"-tx-6-"LV"-noun-0]|TX|2165/2|
00000000|MMI|3.50|Recent|C0332185|[tmco]|["Recent"-tx-4-"recent"-adj-0]|TX|2030/6|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|235/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|235/3|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-20-"dictated"-adj-0]|TX|3356/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-20-"dictated"-adj-0]|TX|3356/8|
00000000|MMI|3.48|mg/mg|C1319635|[qnco]|["mg/mg"-tx-2-"MG MG"-noun-0]|TX|522/2,545/2|
00000000|MMI|3.48|+2|C0740116|[qnco]|["+2"-tx-4-"2"-integer-0]|TX|1218/1|
00000000|MMI|3.48|2+|C3833492|[fndg]|["2+"-tx-4-"2"-integer-0]|TX|1218/1|
00000000|MMI|3.48|2+ Score|C2827735|[qnco]|["2+"-tx-4-"2"-integer-0]|TX|1218/1|
00000000|MMI|3.48|2+ Score, WHO|C2981700|[clas]|["2+"-tx-4-"2"-integer-0]|TX|1218/1|
00000000|MMI|3.48|Cephalexin 500 MG|C0984639|[clnd]|["Cephalexin 500 MG"-tx-2-"CEPHALEXIN 500 MG"-noun-0]|TX|802/17|
00000000|MMI|3.48|Checking (action)|C1283174|[acty]|["Check"-tx-19-"check"-noun-0]|TX|3162/5|
00000000|MMI|3.48|Cheque|C1555524|[mnob]|["Cheque"-tx-19-"check"-noun-0]|TX|3162/5|
00000000|MMI|3.48|Congestion|C0700148|[patf]|["Congestion"-tx-9-"congestion"-noun-0]|TX|2424/10|
00000000|MMI|3.48|HP gene|C1415692|[gngm]|["Bp"-tx-9-"BP"-noun-0]|TX|2309/2|
00000000|MMI|3.48|HP wt Allele|C1708288|[gngm]|["BP"-tx-9-"BP"-noun-0]|TX|2309/2|
00000000|MMI|3.48|Respiratory Domain|C2986904|[idcn]|["RE"-tx-19-"re"-noun-0]|TX|3159/2|
00000000|MMI|3.48|Retinol equivalents|C0556581|[qnco]|["{RE}"-tx-19-"re"-noun-0]|TX|3159/2|
00000000|MMI|3.48|Serious|C0205404|[qlco]|["Serious"-tx-2-"SERIOUS"-adj-0]|TX|720/7|
00000000|MMI|3.48|Tissue Congestion|C2826600|[fndg]|["CONGESTION"-tx-9-"congestion"-noun-0]|TX|2424/10|
00000000|MMI|3.47|4+ Answer to question|C3838679|[fndg]|["4+"-tx-4-"4"-integer-0]|TX|1300/1|
00000000|MMI|3.47|ALPP gene|C1412365|[gngm]|["PALP"-tx-7-"palp"-noun-0]|TX|2215/4|
00000000|MMI|3.47|ALPP wt Allele|C3812647|[gngm]|["PALP"-tx-7-"palp"-noun-0]|TX|2215/4|
00000000|MMI|3.47|Brain natriuretic peptide measurement|C1095989|[lbpr]|["BNP"-tx-9-"BNP"-noun-0]|TX|2497/3|
00000000|MMI|3.47|Clipperton Island|C4050020|[geoa]|["CP"-tx-7-"CP"-noun-0]|TX|2212/2|
00000000|MMI|3.47|NPPB gene|C1417808|[gngm]|["BNP"-tx-9-"BNP"-noun-0]|TX|2497/3|
00000000|MMI|3.47|NPPB wt Allele|C2982014|[gngm]|["BNP"-tx-9-"BNP"-noun-0]|TX|2497/3|
00000000|MMI|3.47|Palp - CHV concept|C2945620|[cnce]|["palp"-tx-7-"palp"-noun-0]|TX|2215/4|
00000000|MMI|3.47|Primary|C0205225|[qlco]|["Principal"-tx-4-"PRINCIPAL"-adj-0]|TX|1461/9|
00000000|MMI|3.47|Serial Number|C2348188|[inpr]|["SERIAL"-tx-10-"serial"-adj-0]|TX|2591/6|
00000000|MMI|3.47|Sodium Cation|C0597484|[elii]|["Sodium+"-tx-4-"Sodium"-noun-0]|TX|1307/6|
00000000|MMI|3.47|Sodium Drug Class|C3714642|[phsu]|["SODIUM"-tx-4-"Sodium"-noun-0]|TX|1307/6|
00000000|MMI|3.47|Sodium supplements|C3541959|[phsu]|["Sodium"-tx-4-"Sodium"-noun-0]|TX|1307/6|
00000000|MMI|3.47|Teaching principal|C0401925|[prog]|["Principal"-tx-4-"PRINCIPAL"-adj-0]|TX|1461/9|
00000000|MMI|3.47|gram|C0439208|[qnco]|["GRAM"-tx-4-"gram"-noun-0]|TX|1302/4|
00000000|MMI|3.46|Administration procedure|C1533734|[topp]|["Treatment"-tx-4-"Treatment"-noun-0]|TX|1633/9|
00000000|MMI|3.46|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-4-"Treatment"-noun-0]|TX|1633/9|
00000000|MMI|3.46|Now (temporal qualifier)|C1948052|[tmco]|["Now"-tx-4-"now"-adv-0]|TX|2058/3|
00000000|MMI|3.46|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-4-"Treatment"-noun-0]|TX|1633/9|E02
00000000|MMI|3.46|Treating|C1522326|[ftcn]|["Treatment"-tx-4-"Treatment"-noun-0]|TX|1633/9|
00000000|MMI|3.46|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-4-"Treatment"-noun-0]|TX|1633/9|
00000000|MMI|3.46|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-4-"Treatment"-noun-0]|TX|1633/9|
00000000|MMI|3.46|S-11-P|C0073829|[orch]|["S-11-P"-tx-4-"s/p 11"-fraction-0]|TX|1998/3,2022/2|
00000000|MMI|3.46|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-4-"ADA"-noun-0]|TX|1277/3|
00000000|MMI|3.46|CA8 gene|C1413051|[gngm]|["CALS"-tx-4-"cals"-noun-0]|TX|1286/4|
00000000|MMI|3.46|Genus Ada|C1060325|[plnt]|["Ada"-tx-4-"ADA"-noun-0]|TX|1277/3|
00000000|MMI|3.46|Nutrition, Calories|C1556156|[qnco]|["cals"-tx-4-"cals"-noun-0]|TX|1286/4|
00000000|MMI|3.46|Study Day|C2826182|[tmco]|["DY"-tx-4-"dy"-noun-0]|TX|1291/2|
00000000|MMI|3.46|kilocalorie|C0439259|[qnco]|["Cal"-tx-4-"cals"-noun-0]|TX|1286/4|
00000000|MMI|3.45|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-4-"chol"-noun-0]|TX|1245/4|
00000000|MMI|3.45|liter|C0475211|[qnco]|["LITER"-tx-4-"liters"-noun-0]|TX|1220/6|
00000000|MMI|3.45|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-2-"QHS"-noun-0]|TX|891/3|
00000000|MMI|3.45|Three times daily|C0556984|[tmco]|["TID"-tx-2-"TID"-noun-0]|TX|823/3|
00000000|MMI|3.45|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-2-"TID"-noun-0]|TX|823/3|
00000000|MMI|3.45|Cardiac function|C0232164|[ortf]|["Cardiac function"-tx-18-"cardiac function"-noun-0]|TX|3119/16|
00000000|MMI|3.45|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-20-"ED"-noun-0]|TX|3277/2|
00000000|MMI|3.45|Room of building - Study|C0557651|[mnob]|["Study"-tx-4-"Study"-noun-0]|TX|1510/5|
00000000|MMI|3.45|Study|C2603343|[resa]|["Study"-tx-4-"Study"-noun-0]|TX|1510/5|
00000000|MMI|3.44|Immediate Release Dosage Form|C1708470|[bodm]|["Immediate Release"-tx-2-"IMMEDIATE RELEASE"-noun-0]|TX|668/17|
00000000|MMI|3.44|CXADR wt Allele|C3540475|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|115/3|
00000000|MMI|3.44|Coxsackievirus and Adenovirus Receptor|C3539542|[aapp]|["CAR"-tx-1-"CAR"-noun-0]|TX|115/3|
00000000|MMI|3.44|Identifier|C0600091|[inpr]|["ID"-tx-18-"ID"-noun-0]|TX|3034/2|
00000000|MMI|3.44|Immune diffusion|C1441613|[lbpr]|["ID"-tx-18-"ID"-noun-0]|TX|3034/2|
00000000|MMI|3.44|NR1I3 wt Allele|C3811749|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|115/3|
00000000|MMI|3.44|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-4-"h/o"-noun-0]|TX|1974/3|
00000000|MMI|3.43|Back structure, excluding neck|C1995000|[blor]|["Back, NOS"-tx-18-"back"-adj-0]|TX|3076/4|
00000000|MMI|3.43|Back structure, including back of neck|C0460009|[blor]|["Back"-tx-18-"back"-adj-0]|TX|3076/4|
00000000|MMI|3.43|Benign melanocytic nevus|C1456781|[neop]|["mole"-tx-18-"mole"-noun-0]|TX|3065/4|
00000000|MMI|3.43|DUOXA1 gene|C1824986|[gngm]|["mol"-tx-18-"mole"-noun-0]|TX|3065/4|
00000000|MMI|3.43|Dorsal|C0205095|[spco]|["BACK"-tx-18-"back"-adj-0]|TX|3076/4|
00000000|MMI|3.43|Evaluation procedure|C1261322|[hlca]|["Evaluation"-tx-14-"evaluation"-noun-0]|TX|2839/10|
00000000|MMI|3.43|Further|C1517331|[spco]|["Further"-tx-14-"further"-adj-0]|TX|2831/7|
00000000|MMI|3.43|Melanocytic nevus of skin|C3665593|[neop]|["mole"-tx-18-"mole"-noun-0]|TX|3065/4|
00000000|MMI|3.43|Mole, unit of measurement|C0439189|[qnco]|["mol"-tx-18-"mole"-noun-0]|TX|3065/4|
00000000|MMI|3.43|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx